feed,title,long_url,short_url
Benzinga,What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal,https://benzinga.com/general/biotech/22/11/29511199/what-to-watch-in-the-s-p-biotech-etf-after-johnson-johnsons-16-6b-abiomed-deal,https://bit.ly/3TXGBPV
